Synchronous Hepatic Colorectal Metastases: The Evolution from Despair

Approximately 2400 US patients present with Synchronous Colorectal Cancer Hepatic Metastases annually. These patients comprise 15-25% of new cases of colorectal cancer per year. They comprise 25-50% of most large hepatic resection series for colorectal cancer and are believed to represent a patient population with aggressive biology and poor prognosis.

St. David’s Healthcare CME program recognized the significance of ongoing clinical changes in medicine and how often new techniques and outcomes are introduced. We are proud to offer the library of courses available to you, however, cannot guarantee that all courses are presented with the most current information. The course shown above is no longer available for CME credit.